This inventor holds 5 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignee: Intec Pharma Ltd.. Active years: 2014-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2017
Title: Eytan Moor: Innovator in Gastroretentive Drug Delivery Systems
Introduction
Eytan Moor is a prominent inventor based in Jerusalem, Israel. He has made significant contributions to the field of pharmaceutical technology, particularly in the development of gastroretentive drug delivery systems. With a total of 5 patents to his name, Moor's work focuses on enhancing the efficacy of drug formulations for improved patient outcomes.
Latest Patents
One of Moor's latest innovations is the "Zaleplon gastroretentive drug delivery system." This invention features a biodegradable, multi-layered controlled release dosage form that is designed to provide both immediate and controlled release of zaleplon in the gastrointestinal tract. The capsule disintegrates upon contact with gastric juice, allowing for rapid unfolding and efficient sleep induction with minimal next-day residual effects.
Another notable patent is the "Carbidopa/levodopa gastroretentive drug delivery." This formulation is designed for the sustained release of active agents in the gastrointestinal tract. It comprises an internal layer containing the active agent and pharmaceutical excipients, surrounded by membranes that ensure the formulation remains intact until it reaches the desired location in the digestive system.
Career Highlights
Eytan Moor is currently associated with Intec Pharma Ltd., where he continues to innovate in the field of drug delivery systems. His work has been instrumental in advancing the understanding and application of gastroretentive technologies, which are crucial for improving therapeutic outcomes in patients.
Collaborations
Moor has collaborated with notable colleagues such as Nadav Navon and David Kirmayer, contributing to a dynamic research environment that fosters innovation and development in pharmaceutical sciences.
Conclusion
Eytan Moor's contributions to gastroretentive drug delivery systems exemplify the impact of innovative thinking in the pharmaceutical industry. His patents reflect a commitment to enhancing patient care through advanced drug formulations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile